의료 및 진단 검사 서비스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global medical and diagnostic laboratory services market size is expected to reach USD 470.32 Billion in 2034 from USD 224.95 Billion in 2025, growing at a CAGR of 8.54 during 2026-2034.This market is expanding significantly due to growing demand for accurate diagnostic testing and preventive healthcare services. Medical and diagnostic laboratories provide essential testing services for disease detection, monitoring, and treatment planning. Rising prevalence of chronic diseases, increasing healthcare expenditures, and growing awareness of early diagnosis are key factors driving market growth. Healthcare systems are increasingly emphasizing laboratory-based diagnostics to improve patient outcomes.

Technological advancements in molecular diagnostics, automation, and laboratory information management systems are enhancing testing accuracy and efficiency. Growing adoption of personalized medicine and precision diagnostics is creating new opportunities for laboratory service providers. Increasing demand for infectious disease testing, genetic screening, and routine health assessments is further supporting market expansion. Strategic investments in laboratory infrastructure are also contributing to market development.

Future prospects remain highly favorable as healthcare systems continue focusing on preventive and personalized care. Artificial intelligence, digital pathology, and advanced analytics will improve diagnostic capabilities and workflow efficiency. Expanding access to healthcare services in emerging economies will create additional growth opportunities. As demand for accurate and timely diagnostics increases, laboratory services will remain a critical component of healthcare delivery.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

• Diagnostic Imaging Centers (X-ray Imaging, Magnetic Resonance Imaging (MRI), Ultrasound Imaging, Computed Tomography (CT) Scans, Nuclear Imaging, Mammography)
• Medical Laboratory Services (Clinical Chemistry, Hematology, Microbiology, Immunology/Serology, Molecular Diagnostics, Pathology, Blood Banking / Transfusion Services)

By Type of Expenditure

• Public
• Private

By Application

• Cardiology
• Oncology
• Neurology
• Orthopedics
• Gastroenterology
• Gynecology
• Other Applications

By End User Gender

• Male
• Female

COMPANIES PROFILED

• Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Sonic Healthcare Limited, Charles River Laboratories International, Inc., RadNet, Inc., Exact Sciences Corporation, Bio-Techne Corporation, OPKO Health, Inc., Natera, Inc., Myriad Genetics, Inc., NeoGenomics, Inc., Guardant Health, Inc., Veracyte, Inc., Invitae Corporation

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MEDICAL AND DIAGNOSTIC LABORATORY SERVICES MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Diagnostic Imaging Centers (X-ray Imaging, Magnetic Resonance Imaging (MRI), Ultrasound Imaging, Computed Tomography (CT) Scans, Nuclear Imaging, Mammography) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Medical Laboratory Services (Clinical Chemistry, Hematology, Microbiology, Immunology/Serology, Molecular Diagnostics, Pathology, Blood Banking / Transfusion Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MEDICAL AND DIAGNOSTIC LABORATORY SERVICES MARKET: BY TYPE OF EXPENDITURE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type Of Expenditure
• 5.2. Public Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Private Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MEDICAL AND DIAGNOSTIC LABORATORY SERVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Orthopedics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Gastroenterology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Gynecology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MEDICAL AND DIAGNOSTIC LABORATORY SERVICES MARKET: BY END USER GENDER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User Gender
• 7.2. Male Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Female Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MEDICAL AND DIAGNOSTIC LABORATORY SERVICES MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Type Of Expenditure
  • 8.2.3 By Application
  • 8.2.4 By End User Gender
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Type Of Expenditure
  • 8.3.3 By Application
  • 8.3.4 By End User Gender
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Type Of Expenditure
  • 8.4.3 By Application
  • 8.4.4 By End User Gender
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Type Of Expenditure
  • 8.5.3 By Application
  • 8.5.4 By End User Gender
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Type Of Expenditure
  • 8.6.3 By Application
  • 8.6.4 By End User Gender
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MEDICAL AND DIAGNOSTIC LABORATORY SERVICES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Laboratory Corporation Of America Holdings
  • 10.2.2 Quest Diagnostics Incorporated
  • 10.2.3 Eurofins Scientific SE
  • 10.2.4 Sonic Healthcare Limited
  • 10.2.5 Charles River Laboratories InternationalInc
  • 10.2.6 RadNetInc
  • 10.2.7 Exact Sciences Corporation
  • 10.2.8 Bio-Techne Corporation
  • 10.2.9 OPKO HealthInc
  • 10.2.10 NateraInc
  • 10.2.11 Myriad GeneticsInc
  • 10.2.12 NeoGenomicsInc
  • 10.2.13 Guardant HealthInc
  • 10.2.14 VeracyteInc
  • 10.2.15 Invitae Corporation